Cargando…
Exploring the Mechanism and Suggesting Combination Therapies for HDAC Inhibitors in Androgen Receptor-Null Prostate Cancer Using Multivariate Statistical Analysis and Data Mining Techniques
Previously, we showed that novel histone deacetylase (HDAC) inhibitors, N1-hydroxy-N(8)-(4-(pyridine-2-carbothioamido)phenyl)octanediamide (Jazz90) and [chlorido(η(5)-pentamethylcyclopentadienyl)(N1-hydroxy-N8-(4-(pyridine-2-carbothioamido-κ(2)N, S)phenyl)octanediamide)rhodium(III)] chloride (Jazz16...
Autores principales: | Rana, Zohaib, Rosengren, Rhonda J, Smith, Paul F |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9772946/ https://www.ncbi.nlm.nih.gov/pubmed/36570326 http://dx.doi.org/10.1177/11779322221145428 |
Ejemplares similares
-
Cytostatic Action of Novel Histone Deacetylase Inhibitors in Androgen Receptor-Null Prostate Cancer Cells
por: Rana, Zohaib, et al.
Publicado: (2021) -
Understanding Failure and Improving Treatment Using HDAC Inhibitors for Prostate Cancer
por: Rana, Zohaib, et al.
Publicado: (2020) -
Anti-Proliferative, Anti-Angiogenic and Safety Profiles of Novel HDAC Inhibitors for the Treatment of Metastatic Castration-Resistant Prostate Cancer
por: Rana, Zohaib, et al.
Publicado: (2021) -
Raloxifene Suppresses Tumor Growth and Metastasis in an Orthotopic Model of Castration-Resistant Prostate Cancer
por: Palmer, Hannah, et al.
Publicado: (2022) -
Making 'null effects' informative: statistical techniques and inferential frameworks
por: Harms, Christopher, et al.
Publicado: (2018)